ICON selected as Pfizer strategic partner
Development services company ICON has been selected by pharmaceuticals giant Pfizer as a global strategic partner for clinical research and development.
Pfizer Inc. today announced that it is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the optimal mix of businesses for maximizing shareholder value.